60 minutes

60 minutes The price of generics /

Show other versions (4170)

A report on the State of Connecticut's lawsuit alleging major competitors in the generic pharmaceutical drug industry are engaged in a broad conspiracy to overcharge consumers. Connecticut Attorney General William Tong chronicles the way that multiple generic drug manufacturers systemically rai...

Full description

Bibliographic Details
Other Authors:	Lieberman, Marc E. (Producer), Rawaf, Ali (Producer), Whitaker, Bill, 1951- (Interviewer)
Format:	Unknown
Language:	English
Published:	New York, NY : Columbia Broadcasting System (CBS), 2019
Subjects:	Generic drugs > Government policy > United States Generic drugs > Prices > United States Price fixing > United States Interviews Television news programs

Similar Items

60 minutes. The price of generics /
Published: (2019)

The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-day exclusivity period /
by: Olson, Luke M., et al.
Published: (2013)

Trends in brand name and generic prescribed medicine utilization and expenditures, 1999 to 2003 /
by: Stagnitti, Marie N, et al.
Published: (2006)

Generic drug user fee amendments accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session ... January 28, 2016
Published: (2018)

Generic drug user fee amendments : accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining generic drug user fee amendments, focusing on accelerating patient access to generic drugs, January 28, 2016
Published: (2018)

Expanding the use of generic drugs
Published: (2010)

Generic Drugs Under Medicare : Part D Generic Drug Prices Declined Overall, but Some Had Extraordinary Price Increases
Published: (2016)

Generic drug user fee amendments : accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session ... January 28, 2016
Published: (2018)

Generic scrip share and the price of brand-name drugs : the role of consumer choice /
by: Rizzo, John A
Published: (2005)

Generic drugs : the pay-for-delay problem /
Published: (2011)

Why are some generic drugs skyrocketing in price? : hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, second session, on examining the pricing of generic drugs, November 20, 2014
Published: (2017)

Prescription drugs : price trends for frequently used brand and generic drugs from 2000 through 2004: report to congressional requesters /
Published: (2005)

Expanding the use of generic drugs
Published: (2010)

Why are some generic drugs skyrocketing in price? hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, second session, on examining the pricing of generic drugs, November 20, 2014
Published: (2017)

Why are some generic drugs skyrocketing in price? : hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, second session, on examining the pricing of generic drugs, November 20, 2014
Published: (2017)

Creating and Restoring Equal Access to Equivalent Samples Act of 2019 : report (to accompany H.R. 965) (including cost estimate of the Congressional Budget Office)
Published: (2019)

Generic pharmaceuticals : marketplace access and consumer issues : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, second session, April 23, 2002
Published: (2004)

How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry /
by: Cook, Anna
Published: (1998)

Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019 : report (to accompany H.R. 938) (including cost estimate of the Congressional Budget Office)
Published: (2019)

How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry
Published: (1998)

Expanding the use of generic drugs
Published: (2010)

Drug Pricing : Research on Savings from Generic Drug Use
Published: (2012)

Generic drugs: safety and effectiveness
by: Wiener, Harry, et al.
Published: (1973)

How increased competition from generic drugs has affected prices and returns in the pharmaceutical industry
Published: (1998)

Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019 : report (to accompany H.R. 938) (including cost estimate of the Congressional Budget Office)
Published: (2019)

Drug pricing research on savings from generic drug use /
by: Dicken, John E
Published: (2012)

Generic entry and the pricing of pharmaceuticals /
by: Frank, Richard G
Published: (1995)

Generic Drugs : The Pay-for-Delay Problem
by: Curtin, Christina M
Published: (2011)

Generic drugs the pay-for-delay problem /
Published: (2011)

Generic drugs the pay-for-delay problem /
Published: (2011)

Orange Book Transparency Act of 2019 : report (to accompany H.R. 1503) (including cost estimate of the Congressional Budget Office)
Published: (2019)

Creating and Restoring Equal Access to Equivalent Samples Act of 2019 : report (to accompany H.R. 965) (including cost estimate of the Congressional Budget Office)
Published: (2019)

Generic pharmaceuticals : marketplace access and consumer issues : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, second session, April 23, 2002
Published: (2004)

Drug pricing : research on savings from generic drug use /
by: Dicken, John E, et al.
Published: (2012)

Generic drugs : the pay-for-delay problem /
Published: (2011)

Preserve Access to Affordable Generics and Biosimilars Act : report together with additional views (to accompany H.R. 2375) (including cost estimate of the Congressional Budget Office)
Published: (2020)

Preserve Access to Affordable Generics and Biosimilars Act : report together with additional views (to accompany H.R. 2375) (including cost estimate of the Congressional Budget Office)
Published: (2020)

Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearing before the Committee on the Judiciary, United States Senate, One Hundred Tenth Congress, first session, January 17, 2007
Published: (2007)

Prescription drugs : price tends for frequently used brand and generic drugs from 2000 through 2004 : report to congressional requesters
Published: (2005)

Developments in the prescription drug market : oversight : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fourteenth Congress, second session, February 4, 2016
Published: (2017)